Patterns and rates of viral evolution in HIV-1 subtype B infected females and males

PLoS ONE

Volumn 12, Issue 10, 2017, Pages

  Dapp, Michael J ^a   Kober, Kord M ^b   Chen, Lennie ^a   Westfall, Dylan H ^a   Wong, Kim ^a   Zhao, Hong ^a   Hall, Breana M ^g   Deng, Wenjie ^a   Sibley, Thomas ^a   Ghorai, Suvankar ^a,e   Kim, Katie ^a   Chen, Natalie ^a,f   McHugh, Sarah ^a   Au, Lily ^a   Cohen, Mardge ^c   Anastos, Kathryn ^d   Mullins, James I ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Bureau of Health Services of Cook County   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e National Center for Cell Science   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g NONE

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; GLYCOPROTEIN GP 120; NUCLEOTIDE;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; EVOLUTION; FEMALE; GLYCOSYLATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SUBTYPE B; MALE; MICROBIAL DIVERSITY; POTENTIAL N LINKED GLYCOSYLATION; VIRUS LOAD; DISEASE COURSE; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; MOLECULAR EVOLUTION; PHYLOGENY; PHYSIOLOGY; SEXUAL DEVELOPMENT; STATISTICAL MODEL; TIME FACTOR; VIROLOGY;

COHORT STUDIES; DISEASE PROGRESSION; EVOLUTION, MOLECULAR; FEMALE; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GLYCOSYLATION; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; LIKELIHOOD FUNCTIONS; MALE; NUCLEOTIDES; PHYLOGENY; SEX CHARACTERISTICS; TIME FACTORS;

EID: 85031762915     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0182443     Document Type: Article

References (112)

1. Delmas MC, Jadand C, De Vincenzi I, Deveau C, Persoz A, Sobel A, et al. Gender difference in CD4+ cell counts persist after HIV-1 infection. SEROCO Study Group. AIDS. 1997; 11(8):1071–3. PMID: 9223753.
2. Sterling TR, Vlahov D, Astemborski J, Hoover DR, Margolick JB, Quinn TC. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men. N Engl J Med. 2001; 344(10):720–5. Epub 2001/ 03/10. https://doi.org/10.1056/NEJM200103083441003 PMID: 11236775.
3. Gandhi M, Bacchetti P, Miotti P, Quinn TC, Veronese F, Greenblatt RM. Does patient sex affect human immunodeficiency virus levels? Clin Infect Dis. 2002; 35(3):313–22. https://doi.org/10.1086/ 341249 PMID: 12115098.
4. Hatzakis AE, Touloumi G, Pantazis N, Anastassopoulou CG, Katsarou O, Karafoulidou A, et al. Cellular HIV-1 DNA load predicts HIV-RNA rebound and the outcome of highly active antiretroviral therapy. AIDS. 2004; 18(17):2261–7. Epub 2004/12/04. PMID: 15577538.
5. Farzadegan H, Hoover DR, Astemborski J, Lyles CM, Margolick JB, Markham RB, et al. Sex differences in HIV-1 viral load and progression to AIDS. Lancet. 1998; 352(9139):1510–4. Epub 1998/11/ 20. https://doi.org/10.1016/S0140-6736(98)02372-1 PMID: 9820299.
6. Long EM, Martin HL Jr., Kreiss JK, Rainwater SM, Lavreys L, Jackson DJ, et al. Gender differences in HIV-1 diversity at time of infection. Nat Med. 2000; 6(1):71–5. https://doi.org/10.1038/71563 PMID: 10613827
7. Haaland RE, Hawkins PA, Salazar-Gonzalez J, Johnson A, Tichacek A, Karita E, et al. Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1. PLoS pathogens. 2009; 5(1):e1000274. Epub 2009/01/24. https://doi.org/10.1371/journal.ppat.1000274 PMID: 19165325
8. Abrahams MR, Anderson JA, Giorgi EE, Seoighe C, Mlisana K, Ping LH, et al. Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants. J Virol. 2009; 83(8):3556–67. Epub 2009/02/06. https://doi.org/10.1128/JVI.02132-08 PMID: 19193811
9. Carlson JM, Schaefer M, Monaco DC, Batorsky R, Claiborne DT, Prince J, et al. HIV transmission. Selection bias at the heterosexual HIV-1 transmission bottleneck. Science. 2014; 345(6193):1254031. Epub 2014/07/12.
10. Berghofer B, Frommer T, Haley G, Fink L, Bein G, Hackstein H. TLR7 ligands induce higher IFN-alpha production in females. J Immunol. 2006; 177(4):2088–96. PMID: 16887967.
11. Meier A, Chang JJ, Chan ES, Pollard RB, Sidhu HK, Kulkarni S, et al. Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. Nat Med. 2009; 15(8):955–9. Epub 2009/07/15. https://doi.org/10.1038/nm.2004 PMID: 19597505
12. Giorgi JV, Hultin LE, McKeating JA, Johnson TD, Owens B, Jacobson LP, et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis. 1999; 179(4):859–70. https://doi.org/10.1086/314660 PMID: 10068581.
13. Chang JJ, Woods M, Lindsay RJ, Doyle EH, Griesbeck M, Chan ES, et al. Higher expression of several interferon-stimulated genes in HIV-1-infected females after adjusting for the level of viral replication. J Infect Dis. 2013; 208(5):830–8. https://doi.org/10.1093/infdis/jit262 PMID: 23757341
14. Allen TM, Altfeld M, Geer SC, Kalife ET, Moore C, O’Sullivan K M, et al. Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution. J Virol. 2005; 79(21):13239–49. https://doi.org/10.1128/JVI.79.21.13239-13249.2005 PMID: 16227247.
15. Liu Y, McNevin J, Cao J, Zhao H, Genowati I, Wong K, et al. Selection on the human immunodeficiency virus type 1 proteome following primary infection. J Virol. 2006; 80(19):9519–29. https://doi.org/10.1128/JVI.00575-06 PMID: 16973556
16. Shankarappa R, Margolick JB, Gange SJ, Rodrigo AG, Upchurch D, Farzadegan H, et al. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J Virol. 1999; 73(12):10489–502. PMID: 10559367
17. Maldarelli F, Kearney M, Palmer S, Stephens R, Mican J, Polis MA, et al. HIV populations are large and accumulate high genetic diversity in a nonlinear fashion. J Virol. 2013; 87(18):10313–23. https://doi.org/10.1128/JVI.01225-12 PMID: 23678164
18. Vrancken B, Rambaut A, Suchard MA, Drummond A, Baele G, Derdelinckx I, et al. The genealogical population dynamics of HIV-1 in a large transmission chain: bridging within and among host evolutionary rates. PLoS computational biology. 2014; 10(4):e1003505. https://doi.org/10.1371/journal.pcbi. 1003505 PMID: 24699231
19. Alizon S, Fraser C. Within-host and between-host evolutionary rates across the HIV-1 genome. Retrovirology. 2013; 10:49. https://doi.org/10.1186/1742-4690-10-49 PMID: 23639104
20. Lythgoe KA, Fraser C. New insights into the evolutionary rate of HIV-1 at the within-host and epidemiological levels. Proc Biol Sci. 2012; 279(1741):3367–75. https://doi.org/10.1098/rspb.2012.0595 PMID: 22593106
21. Deymier MJ, Ende Z, Fenton-May AE, Dilernia DA, Kilembe W, Allen SA, et al. Heterosexual Transmission of Subtype C HIV-1 Selects Consensus-Like Variants without Increased Replicative Capacity or Interferon-alpha Resistance. PLoS pathogens. 2015; 11(9):e1005154. https://doi.org/10.1371/journal.ppat.1005154 PMID: 26378795
22. Redd AD, Collinson-Streng AN, Chatziandreou N, Mullis CE, Laeyendecker O, Martens C, et al. Previously transmitted HIV-1 strains are preferentially selected during subsequent sexual transmissions. J Infect Dis. 2012; 206(9):1433–42. https://doi.org/10.1093/infdis/jis503 PMID: 22997233
23. Vrancken B, Baele G, Vandamme AM, van Laethem K, Suchard MA, Lemey P. Disentangling the impact of within-host evolution and transmission dynamics on the tempo of HIV-1 evolution. AIDS. 2015; 29(12):1549–56. https://doi.org/10.1097/QAD.0000000000000731 PMID: 26244394.
24. Li H, Bar KJ, Wang S, Decker JM, Chen Y, Sun C, et al. High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men. PLoS pathogens. 2010; 6(5):e1000890. https://doi.org/10.1371/journal.ppat.1000890 PMID: 20485520
25. Keele BF, Giorgi EE, Salazar-Gonzalez JF, Decker JM, Pham KT, Salazar MG, et al. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci U S A. 2008; 105(21):7552–7. Epub 2008/05/21. https://doi.org/10.1073/pnas. 0802203105 PMID: 18490657
26. Fischer W, Ganusov VV, Giorgi EE, Hraber PT, Keele BF, Leitner T, et al. Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing. PLoS One. 2010; 5(8):e12303. Epub 2010/09/03. https://doi.org/10.1371/journal.pone.0012303 PMID: 20808830
27. Jensen MA, Li FS, van’t Wout AB, Nickle DC, Shriner D, He HX, et al. Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences. J Virol. 2003; 77(24):13376–88. https://doi.org/10.1128/JVI.77.24.13376-13388.2003 PMID: 14645592.
28. Rinaldo CR Jr., Gupta P, Huang XL, Fan Z, Mullins JI, Gange S, et al. Anti-HIV type 1 memory cytotoxic T lymphocyte responses associated with changes in CD4+ T cell numbers in progression of HIV type 1 infection. AIDS Res Hum Retroviruses. 1998; 14(16):1423–33. https://doi.org/10.1089/aid.1998.14.1423 PMID: 9824320.
29. Barkan SE, Melnick SL, Preston-Martin S, Weber K, Kalish LA, Miotti P, et al. The Women’s Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology. 1998; 9(2):117–25. PMID: 9504278.
30. Calvelli T, Denny TN, Paxton H, Gelman R, Kagan J. Guideline for flow cytometric immunophenotyping: a report from the National Institute of Allergy and Infectious Diseases, Division of AIDS. Cytometry. 1993; 14(7):702–15. https://doi.org/10.1002/cyto.990140703 PMID: 8243200.
31. Gange SJ, Munoz A, Chmiel JS, Donnenberg AD, Kirstein LM, Detels R, et al. Identification of inflections in T-cell counts among HIV-1-infected individuals and relationship with progression to clinical AIDS. Proc Natl Acad Sci U S A. 1998; 95(18):10848–53. PMID: 9724793
32. Frenkel LM, Mullins JI, Learn GH, Manns-Arcuino L, Herring BL, Kalish ML, et al. Genetic evaluation of suspected cases of transient HIV-1 infection of infants. Science. 1998; 280(5366):1073–7. PMID: 9582120.
33. Frenkel LM, Wang Y, Learn GH, McKernan JL, Ellis GM, Mohan KM, et al. Multiple viral genetic analyses detect low-level human immunodeficiency virus type 1 replication during effective highly active antiretroviral therapy. J Virol. 2003; 77(10):5721–30. https://doi.org/10.1128/JVI.77.10.5721-5730. 2003 PMID: 12719565.
34. Delwart EL, Shpaer EG, Louwagie J, McCutchan FE, Grez M, Rubsamen-Waigmann H, et al. Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes. Science. 1993; 262(5137):1257–61. PMID: 8235655.
35. Liu Y, Holte S, Rao U, McClure J, Konopa P, Swain JV, et al. A sensitive real-time PCR based assay to estimate the impact of amino acid substitutions on the competitive replication fitness of human immunodeficiency virus type 1 in cell culture. J Virol Methods. 2013; 189(1):157–66. Epub 2012/12/ 04. https://doi.org/10.1016/j.jviromet.2012.10.016 PMID: 23201292
36. Liu Y, Curlin ME, Diem K, Zhao H, Ghosh AK, Zhu H, et al. Env length and N-linked glycosylation following transmission of human immunodeficiency virus Type 1 subtype B viruses. Virology. 2008; 374 (2):229–33. Epub 2008/03/04. https://doi.org/10.1016/j.virol.2008.01.029 PMID: 18314154
37. Deng W, Nickle DC, Learn GH, Maust B, Mullins JI. ViroBLAST: a stand-alone BLAST web server for flexible queries of multiple databases and user’s datasets. Bioinformatics. 2007; 23(17):2334–6. Epub 2007/06/26. https://doi.org/10.1093/bioinformatics/btm331 PMID: 17586542.
38. Edgar RC. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic acids research. 2004; 32(5):1792–7. https://doi.org/10.1093/nar/gkh340 PMID: 15034147
39. Rose PP, Korber BT. Detecting hypermutations in viral sequences with an emphasis on G—> A hyper-mutation. Bioinformatics. 2000; 16(4):400–1. PMID: 10869039.
40. Drummond AJ, Rambaut A. BEAST: Bayesian evolutionary analysis by sampling trees. BMC evolutionary biology. 2007; 7:214. Epub 2007/11/13. https://doi.org/10.1186/1471-2148-7-214 PMID: 17996036
41. Rambaut A, Lam TT, Max Carvalho L, Pybus OG. Exploring the temporal structure of heterochronous sequences using TempEst (formerly Path-O-Gen). Virus Evol. 2016; 2(1):vew007. https://doi.org/10.1093/ve/vew007 PMID: 27774300
42. Yang Z. Maximum-likelihood estimation of phylogeny from DNA sequences when substitution rates differ over sites. Molecular biology and evolution. 1993; 10(6):1396–401. PMID: 8277861.
43. Drummond AJ, Ho SY, Phillips MJ, Rambaut A. Relaxed phylogenetics and dating with confidence. PLoS biology. 2006; 4(5):e88. https://doi.org/10.1371/journal.pbio.0040088 PMID: 16683862
44. Griffiths RC, Tavare S. Sampling theory for neutral alleles in a varying environment. Philos Trans R Soc Lond B Biol Sci. 1994; 344(1310):403–10. https://doi.org/10.1098/rstb.1994.0079 PMID: 7800710.
45. Drummond AJ, Nicholls GK, Rodrigo AG, Solomon W. Estimating mutation parameters, population history and genealogy simultaneously from temporally spaced sequence data. Genetics. 2002; 161 (3):1307–20. PMID: 12136032
46. Edo-Matas D, Lemey P, Tom JA, Serna-Bolea C, van den Blink AE, van’t Wout AB, et al. Impact of CCR5delta32 host genetic background and disease progression on HIV-1 intrahost evolutionary processes: efficient hypothesis testing through hierarchical phylogenetic models. Molecular biology and evolution. 2011; 28(5):1605–16. https://doi.org/10.1093/molbev/msq326 PMID: 21135151
47. Darriba D, Taboada GL, Doallo R, Posada D. jModelTest 2: more models, new heuristics and parallel computing. Nat Methods. 2012; 9(8):772. https://doi.org/10.1038/nmeth.2109 PMID: 22847109.
48. Lanave C, Preparata G, Saccone C, Serio G. A new method for calculating evolutionary substitution rates. J Mol Evol. 1984; 20(1):86–93. PMID: 6429346.
49. Deng W, Maust BS, Nickle DC, Learn GH, Liu Y, Heath L, et al. DIVEIN: a web server to analyze phylogenies, sequence divergence, diversity, and informative sites. BioTechniques. 2010; 48(5):405–8. https://doi.org/10.2144/000113370 PMID: 20569214
50. Guindon S, Dufayard JF, Lefort V, Anisimova M, Hordijk W, Gascuel O. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Systematic biology. 2010; 59(3):307–21. https://doi.org/10.1093/sysbio/syq010 PMID: 20525638.
51. Stamatakis A. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics. 2014; 30(9):1312–3. https://doi.org/10.1093/bioinformatics/btu033 PMID: 24451623
52. Yang Z. PAML: a program package for phylogenetic analysis by maximum likelihood. Comput Appl Biosci. 1997; 13(5):555–6. PMID: 9367129.
53. Murrell B, Wertheim JO, Moola S, Weighill T, Scheffler K, Kosakovsky Pond SL. Detecting individual sites subject to episodic diversifying selection. PLoS Genet. 2012; 8(7):e1002764. https://doi.org/10.1371/journal.pgen.1002764 PMID: 22807683
54. Delport W, Poon AF, Frost SD, Kosakovsky Pond SL. Datamonkey 2010: a suite of phylogenetic analysis tools for evolutionary biology. Bioinformatics. 2010; 26(19):2455–7. https://doi.org/10.1093/bioinformatics/btq429 PMID: 20671151
55. Simes RJ. An improved Bonferroni procedure for multiple tests of significance. Biometrika. 1986; 73 (3):4. https://doi.org/10.1093/biomet/73.3.751
56. Jensen MA, Gottlieb GS, van’t Wout AB, Li FS, Nickle DC, Wong K, et al., editors. A Bioinformatic Predictor of Coreceptor Usage Correlates with Markers of Disease Progression and Supports the Gradual Evolution of X4 Virus via R5X4 Intermediates (Poster # 498). 10th Conference on Retroviruses and Opportunistic Infections; 2003; Boston, MA.
57. Zhang M, Gaschen B, Blay W, Foley B, Haigwood N, Kuiken C, et al. Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin. Glycobiology. 2004; 14(12):1229–46. https://doi.org/10.1093/glycob/ cwh106 PMID: 15175256.
58. Pinheiro J, Bates D, DebRoy S, Sarkar D, R_Core_Team. _nlme: Linear and Nonlinear Mixed Effects Models_. R package version 3.1–117 ed2014.
59. Revell LJ. phytools v 0.4–31: An R package for phylogenetic comparative biology (and other things). 2012.
60. Herbeck JT, Nickle DC, Learn GH, Gottlieb GS, Curlin ME, Heath L, et al. Human immunodeficiency virus type 1 env evolves toward ancestral states upon transmission to a new host. J Virol. 2006; 80 (4):1637–44. https://doi.org/10.1128/JVI.80.4.1637-1644.2006 PMID: 16439520
61. Friedrich TC, Dodds EJ, Yant LJ, Vojnov L, Rudersdorf R, Cullen C, et al. Reversion of CTL escape-variant immunodeficiency viruses in vivo. Nat Med. 2004; 10(3):275–81. Epub 2004/02/18. https://doi.org/10.1038/nm998 PMID: 14966520.
62. Leslie AJ, Pfafferott KJ, Chetty P, Draenert R, Addo MM, Feeney M, et al. HIV evolution: CTL escape mutation and reversion after transmission. Nat Med. 2004; 10(3):282–9. https://doi.org/10.1038/ nm992 PMID: 14770175.
63. Kent SJ, Fernandez CS, Dale CJ, Davenport MP. Reversion of immune escape HIV variants upon transmission: insights into effective viral immunity. Trends Microbiol. 2005; 13(6):243–6. https://doi.org/10.1016/j.tim.2005.03.011 PMID: 15936652.
64. Li B, Gladden AD, Altfeld M, Kaldor JM, Cooper DA, Kelleher AD, et al. Rapid reversion of sequence polymorphisms dominates early human immunodeficiency virus type 1 evolution. J Virol. 2007; 81 (1):193–201. https://doi.org/10.1128/JVI.01231-06 PMID: 17065207.
65. Song H, Hora B, Bhattacharya T, Goonetilleke N, Liu MK, Wiehe K, et al. Reversion and T cell escape mutations compensate the fitness loss of a CD8+ T cell escape mutant in their cognate transmitted/ founder virus. PLoS One. 2014; 9(7):e102734. https://doi.org/10.1371/journal.pone.0102734 PMID: 25028937
66. Sunshine JE, Larsen BB, Maust B, Casey E, Deng W, Chen L, et al. Fitness-Balanced Escape Determines Resolution of Dynamic Founder Virus Escape Processes in HIV-1 Infection. J Virol. 2015; 89 (20):10303–18. https://doi.org/10.1128/JVI.01876-15 PMID: 26223634
67. Herbeck JT, Rolland M, Liu Y, McLaughlin S, McNevin J, Zhao H, et al. Demographic processes affect HIV-1 evolution in primary infection before the onset of selective processes. Journal of virology. 2011; 85(15):7523–34. Epub 2011/05/20. https://doi.org/10.1128/JVI.02697-10 PMID: 21593162
68. Shankarappa R, Gupta P, Learn GH, Rodrigo AG, Rinaldo CR, Gorry MC, et al. Evolution of human immunodeficiency virus type 1 envelope sequences in infected individuals with differing disease progression profiles. Virology. 1998; 241(2):251–9. https://doi.org/10.1006/viro.1997.8996 PMID: 9499799.
69. Lau B, Gange SJ, Phair JP, Riddler SA, Detels R, Margolick JB. Rapid declines in total lymphocyte counts and hemoglobin concentration prior to AIDS among HIV-1-infected men. AIDS. 2003; 17 (14):2035–44.
70. Salazar-Gonzalez JF, Martinez-Maza O, Nishanian P, Aziz N, Shen LP, Grosser S, et al. Increased immune activation precedes the inflection point of CD4 T cells and the increased serum virus load in human immunodeficiency virus infection. J Infect Dis. 1998; 178(2):423–30. PMID: 9697722.
71. Shepherd JC, Jacobson LP, Qiao W, Jamieson BD, Phair JP, Piazza P, et al. Emergence and Persistence of CXCR4-Tropic HIV-1 in a Population of Men from the Multicenter AIDS Cohort Study. J Infect Dis. 2008; 198(8):1104–12. Epub 2008/09/12. https://doi.org/10.1086/591623 PMID: 18783316.
72. Margolick JB, Muñoz A, Donnenberg AD, Park LP, Galai N, Giorgi JV, et al. Failure of T-cell homeostasis preceding AIDS in HIV-1 infection. Nature Med. 1995; 1(7):674–80. PMID: 7585150
73. Derdeyn CA, Decker JM, Bibollet-Ruche F, Mokili JL, Muldoon M, Denham SA, et al. Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission. Science. 2004; 303 (5666):2019–22. https://doi.org/10.1126/science.1093137 PMID: 15044802.
74. Chohan B, Lang D, Sagar M, Korber B, Lavreys L, Richardson B, et al. Selection for human immunodeficiency virus type 1 envelope glycosylation variants with shorter V1-V2 loop sequences occurs during transmission of certain genetic subtypes and may impact viral RNA levels. J Virol. 2005; 79 (10):6528–31. https://doi.org/10.1128/JVI.79.10.6528-6531.2005 PMID: 15858037.
75. Frost SD, Liu Y, Pond SL, Chappey C, Wrin T, Petropoulos CJ, et al. Characterization of human immunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype B. J Virol. 2005; 79(10):6523–7. Epub 2005/04/29. https://doi.org/10.1128/JVI.79.10.6523-6527.2005 PMID: 15858036
76. Sagar M, Laeyendecker O, Lee S, Gamiel J, Wawer MJ, Gray RH, et al. Selection of HIV variants with signature genotypic characteristics during heterosexual transmission. J Infect Dis. 2009; 199(4):580–9. Epub 2009/01/16. https://doi.org/10.1086/596557 PMID: 19143562
77. Curlin ME, Zioni R, Hawes SE, Liu Y, Deng W, Gottlieb GS, et al. HIV-1 envelope subregion length variation during disease progression. PLoS pathogens. 2010; 6(12):e1001228. https://doi.org/10.1371/journal.ppat.1001228 PMID: 21187897
78. Koot M, Keet IP, Vos AH, de Goede RE, Roos MT, Coutinho RA, et al. Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann Intern Med. 1993; 118(9):681–8. Epub 1993/05/01. PMID: 8096374.
79. Bjorndal A, Deng H, Jansson M, Fiore JR, Colognesi C, Karlsson A, et al. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J Virol. 1997; 71(10):7478–87. PMID: 9311827
80. Tersmette M, Gruters RA, de Wolf F, de Goede RE, Lange JM, Schellekens PT, et al. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates. J Virol. 1989; 63(5):2118–25. PMID: 2564898
81. van’t Wout AB, Kootstra NA, Mulder-Kampinga GA, Albrecht-van Lent N, Scherpbier HJ, Veenstra J, et al. Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission. J Clin Invest. 1994; 94(5):2060–7. https://doi.org/10.1172/ JCI117560 PMID: 7962552.
82. Zhang LQ, MacKenzie P, Cleland A, Holmes EC, Brown AJ, Simmonds P. Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J Virol. 1993; 67(6):3345–56. Epub 1993/06/01. PMID: 8497055
83. Zhu T, Mo H, Wang N, Nam DS, Cao Y, Koup RA, et al. Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science. 1993; 261(5125):1179–81. Epub 1993/08/27. PMID: 8356453.
84. Gottlieb GS, Heath L, Nickle DC, Wong KG, Leach SE, Jacobs B, et al. HIV-1 variation before seroconversion in men who have sex with men: analysis of acute/early HIV infection in the multicenter AIDS cohort study. J Infect Dis. 2008; 197(7):1011–5. https://doi.org/10.1086/529206 PMID: 18419538
85. Salazar-Gonzalez JF, Salazar MG, Keele BF, Learn GH, Giorgi EE, Li H, et al. Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J Exp Med. 2009; 206(6):1273–89. Epub 2009/06/03. https://doi.org/10.1084/jem.20090378 PMID: 19487424
86. Salazar-Gonzalez JF, Bailes E, Pham KT, Salazar MG, Guffey MB, Keele BF, et al. Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing. J Virol. 2008; 82(8):3952–70. Epub 2008/02/08. https://doi.org/10.1128/JVI.02660-07 PMID: 18256145
87. Sagar M, Lavreys L, Baeten JM, Richardson BA, Mandaliya K, Ndinya-Achola JO, et al. Identification of modifiable factors that affect the genetic diversity of the transmitted HIV-1 population. Aids. 2004; 18(4):615–9. Epub 2004/04/20. PMID: 15090766.
88. Sagar M, Kirkegaard E, Long EM, Celum C, Buchbinder S, Daar ES, et al. Human immunodeficiency virus type 1 (HIV-1) diversity at time of infection is not restricted to certain risk groups or specific HIV-1 subtypes. J Virol. 2004; 78(13):7279–83. https://doi.org/10.1128/JVI.78.13.7279-7283.2004 PMID: 15194805.
89. Chomont N, Hocini H, Gresenguet G, Brochier C, Bouhlal H, Andreoletti L, et al. Early archives of genetically-restricted proviral DNA in the female genital tract after heterosexual transmission of HIV-1. AIDS. 2007; 21(2):153–62. https://doi.org/10.1097/QAD.0b013e328011f94b PMID: 17197805.
90. Boeras DI, Hraber PT, Hurlston M, Evans-Strickfaden T, Bhattacharya T, Giorgi EE, et al. Role of donor genital tract HIV-1 diversity in the transmission bottleneck. Proceedings of the National Academy of Sciences of the United States of America. 2011; 108(46):E1156–63. Epub 2011/11/09. https://doi.org/10.1073/pnas.1103764108 PMID: 22065783
91. Rademeyer C, van Harmelen JH, Ramjee G, Karim SS, Williamson C. Heterosexual transmission of multiple highly conserved viral variants in HIV-1 subtype C-infected seronegative women. AIDS. 2004; 18(15):2096–8. PMID: 15577636.
92. Gouveia NL, Camargo M, Caseiro MM, Janini LM, Sucupira MC, Diaz RS. Homogenous HIV-1 subtype B quasispecies in Brazilian men and women recently infected via heterosexual transmission. Virus Genes. 2014; 48(3):421–8. https://doi.org/10.1007/s11262-014-1048-x PMID: 24526349.
93. Lemey P, Kosakovsky Pond SL, Drummond AJ, Pybus OG, Shapiro B, Barroso H, et al. Synonymous substitution rates predict HIV disease progression as a result of underlying replication dynamics. PLoS computational biology. 2007; 3(2):e29. https://doi.org/10.1371/journal.pcbi.0030029 PMID: 17305421
94. Williamson S, Perry SM, Bustamante CD, Orive ME, Stearns MN, Kelly JK. A statistical characterization of consistent patterns of human immunodeficiency virus evolution within infected patients. Molecular biology and evolution. 2005; 22(3):456–68. https://doi.org/10.1093/molbev/msi029 PMID: 15509726.
95. Leitner T, Albert J. The molecular clock of HIV-1 unveiled through analysis of a known transmission history. Proceedings of the National Academy of Sciences of the United States of America. 1999; 96 (19):10752–7. Epub 1999/09/15. PMID: 10485898
96. Korber B, Muldoon M, Theiler J, Gao F, Gupta R, Lapedes A, et al. Timing the ancestor of the HIV-1 pandemic strains. Science. 2000; 288(5472):1789–96. PMID: 10846155.
97. Seo T-K, Thorne JL, Hasegawa M, Kishino H. Estimation of Effective Population Size of HIV-1 Within a Host: A Pseudomaximum-Likelihood Approach. Genetics. 2002; 160(4):1283–93. PMID: 11973287.
98. Jenkins GM, Rambaut A, Pybus OG, Holmes EC. Rates of molecular evolution in RNA viruses: a quantitative phylogenetic analysis. J Mol Evol. 2002; 54(2):156–65. https://doi.org/10.1007/s00239-001-0064-3 PMID: 11821909.
99. Lemey P, Rambaut A, Pybus OG. HIV evolutionary dynamics within and among hosts. AIDS Rev. 2006; 8(3):125–40. PMID: 17078483.
100. Novitsky V, Wang R, Rossenkhan R, Moyo S, Essex M. Intra-host evolutionary rates in HIV-1C env and gag during primary infection. Infection, genetics and evolution: journal of molecular epidemiology and evolutionary genetics in infectious diseases. 2013; 19:361–8. Epub 2013/03/26. https://doi.org/10.1016/j.meegid.2013.02.023 PMID: 23523818
101. Piantadosi A, Chohan B, Panteleeff D, Baeten JM, Mandaliya K, Ndinya-Achola JO, et al. HIV-1 evolution in gag and env is highly correlated but exhibits different relationships with viral load and the immune response. AIDS. 2009; 23(5):579–87. Epub 2009/06/12. https://doi.org/10.1097/QAD. 0b013e328328f76e PMID: 19516110
102. Zanini F, Brodin J, Thebo L, Lanz C, Bratt G, Albert J, et al. Population genomics of intrapatient HIV-1 evolution. eLife. 2015; 4. https://doi.org/10.7554/eLife.11282 PMID: 26652000
103. Schuitemaker H, Koot M, Kootstra NA, Dercksen MW, de Goede RE, van Steenwijk RP, et al. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. J Virol. 1992; 66(3):1354–60. PMID: 1738194.
104. Esbjornsson J, Mansson F, Martinez-Arias W, Vincic E, Biague AJ, da Silva ZJ, et al. Frequent CXCR4 tropism of HIV-1 subtype A and CRF02_AG during late-stage disease—indication of an evolving epidemic in West Africa. Retrovirology. 2010; 7:23. https://doi.org/10.1186/1742-4690-7-23 PMID: 20307309
105. Schuitemaker H, van’t Wout AB, Lusso P. Clinical significance of HIV-1 coreceptor usage. J Transl Med. 2011; 9 Suppl 1:S5. https://doi.org/10.1186/1479-5876-9-S1-S5 PMID: 21284904
106. de Mendoza C, Van Baelen K, Poveda E, Rondelez E, Zahonero N, Stuyver L, et al. Performance of a population-based HIV-1 tropism phenotypic assay and correlation with V3 genotypic prediction tools in recent HIV-1 seroconverters. Journal of acquired immune deficiency syndromes. 2008; 48(3):241–4. https://doi.org/10.1097/QAI.0b013e3181734f0e PMID: 18545159.
107. de Mendoza C, Rodriguez C, Garcia F, Eiros JM, Ruiz L, Caballero E, et al. Prevalence of X4 tropic viruses in patients recently infected with HIV-1 and lack of association with transmission of drug resistance. The Journal of antimicrobial chemotherapy. 2007; 59(4):698–704. https://doi.org/10.1093/jac/ dkm012 PMID: 17327295.
108. Eshleman SH, Husnik M, Hudelson S, Donnell D, Huang Y, Huang W, et al. Antiretroviral drug resistance, HIV-1 tropism, and HIV-1 subtype among men who have sex with men with recent HIV-1 infection. AIDS. 2007; 21(9):1165–74. https://doi.org/10.1097/QAD.0b013e32810fd72e PMID: 17502727.
109. Baan E, van der Sluis RM, Bakker ME, Bekker V, Pajkrt D, Jurriaans S, et al. Human immunodeficiency virus type 1 gp120 envelope characteristics associated with disease progression differ in family members infected with genetically similar viruses. The Journal of general virology. 2013; 94(Pt 1):20–9. https://doi.org/10.1099/vir.0.046185-0 PMID: 23015744.
110. Liu SL, Mittler JE, Nickle DC, Mulvania TM, Shriner D, Rodrigo AG, et al. Selection for human immunodeficiency virus type 1 recombinants in a patient with rapid progression to AIDS. Journal of virology. 2002; 76(21):10674–84. Epub 2002/10/09. https://doi.org/10.1128/JVI.76.21.10674-10684.2002 PMID: 12368309
111. Maljkovic Berry I, Ribeiro R, Kothari M, Athreya G, Daniels M, Lee HY, et al. Unequal evolutionary rates in the human immunodeficiency virus type 1 (HIV-1) pandemic: the evolutionary rate of HIV-1 slows down when the epidemic rate increases. J Virol. 2007; 81(19):10625–35. https://doi.org/10.1128/JVI.00985-07 PMID: 17634235
112. Duffy S, Shackelton LA, Holmes EC. Rates of evolutionary change in viruses: patterns and determinants. Nat Rev Genet. 2008; 9(4):267–76. https://doi.org/10.1038/nrg2323 PMID: 18319742.